Bristol-Myers Squibb (BMY)

NYSE: BMY · Real-Time Price · USD

49.85

-0.35 (-0.70%)

At close: May 01, 2025, 2:15 PM

Bristol-Myers Squibb Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	48.3B	45.01B	46.16B	46.38B	42.52B	26.14B	22.56B	20.78B	19.43B
Cost of Revenue	13.97B	10.69B	10.14B	9.94B	11.77B	8.08B	6.55B	6.07B	4.95B
Gross Profit	34.33B	34.31B	36.02B	36.45B	30.75B	18.07B	16.01B	14.71B	14.48B
Operating Income	5.89B	17.24B	10.33B	10.16B	5.13B	5.46B	5.12B	3.45B	4.54B
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-8.38B	8.44B	7.71B	8.1B	-6.87B	4.97B	6.01B	5.13B	5.92B
Net Income	-8.95B	8.03B	6.33B	6.99B	-8.99B	3.44B	4.95B	1.01B	4.46B
Selling & General & Admin	8.41B	7.77B	7.81B	7.69B	7.66B	4.87B	4.55B	4.85B	5B
Research & Development	11.16B	9.3B	9.51B	10.2B	11.14B	6.15B	6.34B	6.41B	4.94B
Other Expenses	n/a	n/a	9.6B	10.02B	9.76B	1.14B	1.37B	1.4B	1B
Operating Expenses	32.4B	17.89B	26.92B	27.91B	28.57B	12.15B	10.9B	11.26B	9.94B
Interest Expense	1.95B	1.17B	1.23B	1.33B	1.42B	656M	183M	196M	167M
Selling & Marketing Expenses	n/a	1.4B	7.81B	7.69B	7.66B	4.87B	4.55B	4.69B	4.91B
Cost & Expenses	44.35B	28.41B	37.05B	37.85B	40.34B	20.23B	17.44B	17.33B	14.89B
Income Tax Expense	554M	400M	1.37B	1.08B	2.12B	1.51B	1.03B	4.16B	1.41B
Shares Outstanding (Basic)	2.03B	2.07B	2.13B	2.22B	2.26B	1.71B	1.63B	1.65B	1.67B
Shares Outstanding (Diluted)	2.03B	2.08B	2.15B	2.25B	2.26B	1.71B	1.64B	1.65B	1.68B
EPS (Basic)	-4.41	3.88	2.97	3.15	-3.98	2.02	3.03	0.61	2.67
EPS (Diluted)	-4.41	3.86	2.95	3.12	-3.98	2.01	3.03	0.61	2.65
EBITDA	3.17B	19.42B	19.23B	20.19B	5.04B	7.44B	6.85B	6.2B	4.63B
EBIT	-6.43B	9.61B	8.95B	9.43B	-5.45B	5.63B	6.15B	5.33B	6.08B
Depreciation & Amortization	9.6B	9.81B	10.29B	10.76B	10.49B	1.81B	703M	872M	626M